Cynthia Collins has served as a Certara director since 2021 and sits on the Audit Committee; she provided notice of her resignation effective upon the election of the Class III directors at the May 14, 2026 annual meeting. She has been CEO of several pharmaceutical and biotechnology companies, most recently Editas Medicine, and earlier Human Longevity, GenVec and Sequoia Pharmaceuticals, with senior roles at GE Healthcare, Beckman Coulter and Baxter Healthcare. She has served on the boards of Codexis, DermTech and MaxCyte.